Viveve (OTC:VIVMD) said today that it’s planning to raise $11.5 million, having executed a 1-for-8 reverse stock split, as part of its uplisting from the over-the-counter exchange to the NASDAQ board. Sunnyvale, Calif.-based Viveve makes a non-surgical treatment for post-partum laxity of the vaginal introitus. The company put the reverse split into place yesterday; today Viveve said it plans to hit […]
Viveve
Women’s health company Viveve names Patricia Scheller CEO | Personnel Moves
Women’s health devices maker Viveve appoints Patricia Scheller CEO
Privately held Viveve today named Patricia Scheller CEO, also adding her to the company’s board of directors.
Scheller has spent more than 25 years in the health care industry, including as CEO of Prescient Medical and SomaLogic.